China COVID-19 Vaccine Tracker

(No longer being updated since December 28, 2022) 

Our follow-up project – China’s Emerging Global Vaccine Footprint – looks at how China and other countries are supporting local vaccine manufacturing in the post-COVID era.

Since the outbreak of the pandemic, China has committed to making its COVID-19 vaccines a global public good. On multiple occasions, high-level Chinese officials have declared that China is fulfilling this pledge by exporting and donating its COVID-19 vaccines to as many countries that it can. This has generated a great deal of interest and discussion amongst experts from various fields. As an independent, mission-driven consultancy that tracks China’s impact on global health, Bridge Consulting aims to examine and offer a comprehensive picture of China’s vaccine outreach, hopefully enabling more informed discussions on this issue worldwide.

Read more about our methodology here.

1.853B (+0M) DOSES SOLD

328M (+0M) DOSES DONATED

1.653B (+0M) DOSES DELIVERED

Updated as of 13:00 pm (GMT+8), December  28, 2022.

This tracker is no longer being updated.

It includes all bilateral and multilateral sales, donations, and deliveries that have been officially reported through publicly accessible sources.

 Total and Weekly Tracker Highlights

    • Africa Update: Total Sales – 126.4M (+0) | Total Pledged Donations – 152.8M (+0) | Total Deliveries – 153.2M (+0)
    • Asia Pacific Update: Total Sales – 944.9M (+0) | Total Pledged Donations – 143M (+0) | Total Deliveries – 909.8M (+0)
    • Europe Update: Total Sales – 123.5M (+0) | Total Pledged Donations – 5.6M (+0) | Total Deliveries – 59.5M (+0)
    • Latin America Update*: Total Sales – 397.9M (+o) | Total Pledged Donations – 13.4M (+0) | Total Deliveries – 296.8M (o)
    • COVAX Update*: Total Sales – 259.8M (+0) | Total Deliveries – 234.0M (+0)

    *Weekly updates in brackets. 

See #ChinaCOVID19Tracker on Twitter